Men and women 18 to 65 years old who have schizophrenia and abuse alcohol are invited to see if they may qualify for the Breakaway Study. The purpose of this clinical research study is to evaluate the safety and effectiveness of an investigational medication for those diagnosed with schizophrenia and alcohol use disorder.
Each individual will be evaluated to determine his or her eligibility. Those who qualify will receive the investigational medication, study-related medical exams, and laboratory tests at no cost. Compensation for time and travel may also be available.